BioSpace News Archive

Business

BMS Bets up to $1.9 Billion on GentiBio’s Treg Platform for IBD

In partnership with GentiBio, BMS aims to harness the capabilities of engineered Treg therapies to re-establish immune tolerance and repair tissue in patients living with IBD.

August 10, 2022
·
4 min read
·
Alex Keown
MIT Makes Possible Breakthrough in Enabling Implantable Insulin Device

If established as safe and effective in humans, this technology could prove transformative in treating many diseases, such as diabetes.

August 10, 2022
·
3 min read
·
Tristan Manalac
Policy

Merck’s Blockbuster Diabetes Drug Sitagliptin Found Contaminated with Potential Carcinogen

The FDA will still allow continued distribution of sitagliptin containing NTTP with an acceptable intake limit of 37 ng per day and up to 246.7 ng per day.

August 10, 2022
·
3 min read
·
Tristan Manalac
Unpacking the Conundrum of the High Cost of Healthcare

Healthcare improvement leaders from Concordia University and Premier Inc. say the reasons behind the high cost of healthcare are multifaceted and point out the actual price of innovation.

August 10, 2022
·
5 min read
·
Gail Dutton
Cardiac Biomarker Diagnostic Kits Market is Growing at a CAGR of 5.2% from 2022 to 2030

According to the report, the global cardiac biomarker diagnostic kits market was valued at US$ 2.2 Bn in 2021 and is anticipated to grow at a CAGR of 5.2% from 2022 to 2030

August 10, 2022
·
6 min read
Cure Rare Disease Scores IND for First-in-Human CRISPR Therapeutic

CRD’s CRD-TMH-001 is expected to upregulate an alternate form of the dystrophin protein with CRISPR technology and stabilize or reverse the symptoms associated with DMD.

August 10, 2022
·
3 min read
·
Alex Keown
Drug Development

Langya Virus Outbreak Sounds Alarm as Monkeypox, COVID-19 Continue to Spread

Monkeypox is spreading, COVID-19 stubbornly persists and on Tuesday, news broke of a Langya henipavirus outbreak in China.

August 10, 2022
·
6 min read
·
Mark Terry
Global Roundup: Connect in Pharma, CanSino Biologics, HUTCHMED and More

The big Connect in Pharma conference is coming up with digitization and supply chain on the agenda and CanSino Biologics, HUTCHMED and more have positive research news.

August 10, 2022
·
5 min read
·
Alex Keown
Deals

Endo Files for Bankruptcy in Wake of Opioid Lawsuits and Mounting Debt - Updated

Endo International filed for bankruptcy Tuesday in the U.S. Bankruptcy Court in New York due to its debt load of over $8 billion and the thousands of opioid lawsuits.

August 10, 2022
·
4 min read
·
Alex Keown
Deals

Disc Absorbs Gemini in Bid to Propel Hematology Pipeline

Gemini Therapeutics and Disc Medicine have announced plans to merge in an all-stock deal. The combined company will work to advance Disc’s pipeline of hematology programs.

August 10, 2022
·
3 min read
·
Mark Terry